Alembic Pharmaceuticals has announced 12% increase in net profit for first quarter results. The company reported net profit of Rs 30.83 crore for the quarter ending June 2012 compared to June 2011 net profit of Rs 27.56 crore.
The Vadodara based pharmaceutical company has announced entry in dermatology segment with launch of team of 100 people to register better sales volume. Dermatology market has better margins.
The company registered sales worth Rs 197 crore during the quarter compared to Rs 172 crore during the same quarter last year in domestic formulations business. The sales were lower in international generic formulations at Rs 46 crore compared to Rs 61 crore.
The stock was trading at Rs 15.25 on Bombay Stock Exchange. The stock has touched 52-week high and low of Rs 22.35 and 13.55 respectively.